Height and bone mineral density are associated with naevus count supporting the importance of growth in melanoma susceptibility

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Ribero, Simone ^a,b   Glass, Daniel ^a,c   Aviv, Abraham ^d   Spector, Timothy David ^a   Bataille, Veronique ^e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^e WEST HERTFORDSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY GROWTH; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE CELL; BONE DENSITY; BONE MASS; CANCER RISK; CANCER SUSCEPTIBILITY; CELL COUNT; CELL LINEAGE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; HUMAN; LEUCOCYTE TELOMERE LENGTH; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; NAEVUS COUNT; NEURAL CREST; ONCOLOGICAL PARAMETERS; PHENOTYPE; TELOMERE HOMEOSTASIS; TWINS; UNITED KINGDOM; BIOMETRY; CLINICAL TRIAL; DIZYGOTIC TWINS; MALE; METABOLISM; MIDDLE AGED; MONOZYGOTIC TWINS; NEVUS; PATHOLOGY; RISK FACTOR; SKIN TUMOR;

ADULT; AGED; BIOMETRY; BODY HEIGHT; BONE DENSITY; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS; RISK FACTORS; SKIN NEOPLASMS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84921772042     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116863     Document Type: Article

References (51)

1. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, et al. (2005) Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41: 28-44. doi: 10.1016/j.ejca. 2004.10.015 PMID: 15617989
2. Zhu G, Duffy DL, Eldridge A, Grace M, Mayne C, et al. (1999) A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65:483-492. doi: 10.1086/302494 PMID: 10417291
3. Bataille V, Snieder H, MacGregor AJ, Sasieni P, Spector TD (2000) Genetics of risk factors for melanoma: an adult twin study of naevi and freckles. J Natl Cancer Inst 92: 457-463. doi: 10.1093/jnci/92.6. 457 PMID: 10716963
4. Wachsmuth RC, Gaut RM, Barrett JH, Saunders CL, Randerson-Moor JA, et al. (2001) Heritability and gene-environment interactions for melanocytic naevus density examined in a U.K. adolescent twin study. J Invest Dermatol 117: 348-352. doi: 10.1046/j.0022-202x.2001.01415.x PMID: 11511314
5. Newton JA, Bataille V, Griffiths K, Squire JM, Sasieni P, et al. (1993) How common is the Atypical Mole Syndrome in apparently sporadic melanoma. J Am Acad Dermatol 29: 989-996. doi: 10.1016/0190-9622(93)70279-3 PMID: 8245266
6. Bataille V, Kato BS, Falchi M, Gardner J, Kimura M, et al. (2007) Naevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev 16: 1499-1502. doi: 10.1158/1055-9965.EPI-07-0152 PMID: 17627017
7. Nan H, Du M, De Vivo I, Manson JE, Liu S, et al. (2011) Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res 71: 6758-6763. doi: 10.1158/0008-5472.CAN-11-1988 PMID: 22028319
8. Han J, Qureshi AA, Prescott J, Guo Q, Ye L, et al. (2009) A prospective study of telomere length and the risk of skin cancer J Invest Dermatol 129: 415-21. doi: 10.1038/jid.2008.238 PMID: 18668136
9. Valdes AM, Richards JB, Gardner JP, Swaminathan R, Kimura M, et al. (2007) Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporosis Int 18: 1203-1210. doi: 10.1007/s00198-007-0357-5 PMID: 17347788
10. Wallin A, Larsson SC (2011) Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 47: 1606-15. doi: 10.1016/j.ejca.2011.01.020 PMID: 21354783
11. Chen Y, Wang X, Wang J, Yan Z, Luo J (2012).Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies Eur J Cancer 48: 2137-45. doi: 10.1016/j.ejca.2012. 02.063 PMID: 22446023
12. Azvolinsky A (2014) Cancer Risk: The Fat Tissue-BMI-Obesity Connection J Natl Cancer Inst. 2014 Apr; 106(4):dju100. doi: 10.1093/jnci/dju100 PMID: 24685924
13. Peterson E, De P, Nuttall R (2012) BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One. 7: e29177. doi: 10.1371/journal.pone.0029177 PMID: 22276106
14. Han X, Stevens J, Truesdale KP, Bradshaw PT, Kucharska-Newton A, et al. (2014) Body mass index at early adulthood, subsequent weight change, and cancer incidence and mortality. Int J Cancer. 2014 doi: 10.1002/ijc.28930 PMID: 24771654
15. Renehan A, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371: 569-78. doi: 10.1016/S0140-6736(08)60269-X PMID: 18280327
16. Nagel G, Bjørge T, Stocks T, Manjer J, Hallmans G, et al. (2012) Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). Br J Dermatol 167: 59-67. doi: 10.1111/j. 1365-2133.2012.10974.x PMID: 22530854
17. Sergentanis TN, Antoniadis AG, Gogas HJ, Antonopoulos CN, Adami HO, et al. (2013). Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur J Cancer. 49: 642-57. doi: 10.1016/j.ejca.2012.08.028 PMID: 23200191
18. Tang JY, Henderson MT, Hernandez-Boussard T, Kubo J, Desai M, et al. (2013) Lower skin cancer risk in women with higher body mass index: the women's health initiative observational study. Cancer Epidemiol Biomarkers Prev. 22: 2412-5. doi: 10.1158/1055-9965.EPI-13-0647 PMID: 24042260
19. Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, et al. (2001) Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res. 4: 464-77. doi: 10.1375/1369052012803 PMID: 11780939
20. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, et al. (1996) Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer. 73:1605-11. doi: 10.1038/bjc.1996.302 PMID: 8664138
21. Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton Bishop J, et al. (1998) The association between naevi and melanoma in populations with different levels of sun exposure. A joint case-control study of melanoma in the UK and Australia. Br J Cancer. 77: 505-510. doi: 10.1038/bjc.1998.81 PMID: 9472652
22. Gallus S, Naldi L, Martin L, Martinelli M, La Vecchia C, et al. (2006) Anthropometric measures and risk of cutaneous malignant melanoma: a case-control study from Italy. Melanoma Res. 16:83-7. doi: 10. 1097/01.cmr.0000194429.77643.76 PMID: 16432461
23. Olsen CM, Green AC, Zens MS, Stukel TA, Bataille V, et al. (2008). Anthropometric factors and risk of melanoma in women. A pooled anlysis. Int J Cancer. 122:1100-8. doi: 10.1002/ijc.23214 PMID: 17990316
24. Walter RB, Brasky TM, Buckley SA, Potter JD, White E (2013) Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 105: 860-868. doi: 10.1093/jnci/djt102 PMID: 23708052
25. Green J, 1, Cairns BJ, Casabonne D, Wright FL, Reeves G, et al. (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 12:785-94. doi: 10.1016/S1470-2045(11)70154-1 PMID: 21782509
26. Andersen ZJ, Baker JL, Bihrmann K, Vejborg I, Sørensen TI, et al. (2014) Birth weight, childhood body mass index, and height in relation to mammographic density and breast cancer: a register-based cohort study. Breast Cancer Res. 20; 16:R4. doi: 10.1186/bcr3596 PMID: 24443815
27. Renehan AG (2011) Height and cancer: consistent links, but mechanisms unclear The Lancet Oncology 12: 716-717. doi: 10.1016/S1470-2045(11)70193-0 PMID: 21782510
28. Hemminki K, Zhang H, Czene K (2003) Socioeconomic factors in cancer in Sweden. Int J Cancer 105: 692-700. doi: 10.1002/ijc.11150 PMID: 12740920
29. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, et al. (2008) Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol 26: 66-75. doi: 10.1200/JCO.2007.12.3604 PMID: 18165642
30. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature; 436:720-724. doi: 10.1038/ nature03890 PMID: 16079850
31. Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, et al. (2006) Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 95: 496-505. doi: 10.1038/sj.bjc. 6603283 PMID: 16880792
32. Peeper DS (2011) Oncogene-induced senescence and melanoma. Where do we stand? Pigment Cell Melanoma Res 24: 1107-1011. doi: 10.1111/j.1755-148X.2011.00933.x PMID: 22018309
33. Vredeveld LC, Possik PA, Smit MA, Meissl K, Michaloglou C, et al. (2012) Abrogation of BRAFV600Einduced senescence by P13K pathway activation contributes to melanogenesis. Genes Dev 26: 1055-1069. doi: 10.1101/gad.187252.112 PMID: 22549727
34. Beauséjour CM, Krtolica A, Galimi F, Narita M, Lowe SW, et al. (2003) Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22: 4212-4222. doi: 10.1093/emboj/cdg417 MID: 12912919
35. Matheu A, Maraver A, Serrano M (2008) The Arf/p53 pathway in cancer and ageing. Cancer Res 68: 6031-6034. doi: 10.1158/0008-5472.CAN-07-6851 PMID: 18676821
36. Tran SL, Haferkamp S, Scurr LL, Gowrishankar K, Becker TM, et al. (2012) Absence of distinguishing senescence traits in human melanocytic naevi. J Invest Dermatol 132:2226-2234. doi: 10.1038/jid. 2012.126 PMID: 22513787
37. Guthrie JR, Ebeling PR, Hopper JL, Barrett-Connor E, Dennerstein L, et al. (1998) A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 8: 282-290. doi: 10.1007/ s001980050066 PMID: 9797914
38. Zhai G, Hart DJ, Valdes AM, Kato BS, Richards JB, et al. (2008) Natural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based study. Osteoporos Int 19: 1211-7. doi: 10.1007/s00198-008-0562-x PMID: 18305885
39. Nelms BL, Labosky PA (2010) Transcriptional Control of Neural Crest Development. San Rafael (CA): Morgan & Claypool Life Sciences. Developmental Biology.
40. Harris ML, Baxter LL, Loftus SK, Pavan WJ (2010) Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res 23: 496-513. doi: 10.1111/j.1755-148X.2010.00711.x PMID: 20444197
41. Clewes O, Narytnyk A, Gillinder KR, Loughney AD, Murdoch AP, et al. (2011) Characterization and directed differentiation into osteocytes and melanocytes. Stem cell Rev 7: 799-814. doi: 10.1007/ s12015-011-9255-5 PMID: 21455606
42. Richards JB, Zheng HF, Spector TD (2012) Genetics of osteoporosis from genome wide association studies: advances and challenges. Nat Rev Genet 18: 576-588. doi: 10.1038/nrg3228 PMID: 22805710
43. Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, et al. (2011) A novel recurring mutation in MITF predisposes to familial and sporadic melanoma. Nature 480: 99-103. doi: 10.1038/ nature10630 PMID: 22080950
44. Koh JM, Kim GS, Oh B, Lee JY, Park BL (2007) Microphthalmia-associated transcription factor polymorphisms and association with bone mineral density of the proximal femur in postmenopausal women. Mol Cells 23: 246-251. PMID: 17464203
45. Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, et al. (2011) TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res 71: 5606-10. doi: 10.1158/0008-5472. CAN-11-1194 PMID: 21862631
46. Zuo C, Huang Y, Bajis R, Sahih M, Li YP, et al. (2012) Osteoblastogenesis regulation signals in bone remodeling. Osteoporos Int 23: 1653-1663. doi: 10.1007/s00198-012-1909-x PMID: 22290242
47. Na YR, Seok SH, Kim DJ, Han JH, Kim TH, et al. (2009) Bone morphogenetic protein 7 induces mesen-hymal-to-epithelial transition in melanoma cells leading to inhibition of metastasis. Cancer Sci 100: 2218-2225. doi: 10.1111/j.1349-7006.2009.01301.x PMID: 19735263
48. Law MH, MacGregor S, Hayward NK (2012) Melanoma Genetics. Recent findings take us beyond welltraveled pathways. J Invest Dermatol 132: 1763-1774. doi: 10.1038/jid.2012.75 PMID: 22475760
49. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, et al. (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 6122: 957-959. doi: 10.1126/science.1229259 PMID: 23348506
50. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, et al. (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339: 959-961. doi: 10.1126/science.1230062 PMID: 23348503
51. Tripardi R, Stuppia L, Alberti S (2013) Human height genes and cancer. Reviews on Cancer Biochimica et Biophysica Acta (BBA) 1836: 27-41. doi: 10.1016/j.bbcan.2013.02.002 PMID: 23428607